Dr. Servando G. De Los Angeles, MD

Dr. De Los Angeles practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Dr. De Los Angeles' NPI, 1831119619, was assigned on July 21, 2006. Dr. De Los Angeles holds Connecticut license 031177.

Dr. De Los Angeles' primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

Dr. De Los Angeles' primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. The medical group on file is Greenwich Hospital. Dr. De Los Angeles' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. De Los Angeles practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. De Los Angeles' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. De Los Angeles is licensed in Connecticut.

CMS data shows 578 Medicare services from Dr. De Los Angeles across 3 procedure codes in 2024, for 550 Medicare patients. Medicare paid $59,290 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 550 Medicare patients who saw Dr. De Los Angeles in 2024. The largest group is 75 to 84, with 199 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. De Los Angeles' median patient age at 68, with 58% women.

In 2024, Dr. De Los Angeles wrote 434 Medicare Part D claims for 260 patients. 96% of them were for generic drugs. CMS names the drug for 307 of them, across 14 drugs with 11 or more claims each, at $2,667 in total drug cost. In 2023, CMS named 258 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. De Los Angeles for performance year 2024, reported as part of a group. Dr. De Los Angeles accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. De Los Angeles from 1 drug or device company from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $34.